Genetic modification of cerebral arterial wall

Implications for prevention and treatment of cerebral vasospasm

Anantha Vijay, R. Santhanam, Zvonimir S Katusic

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Genetic modification of cerebral vessels represents a promising and novel approach for prevention and/or treatment of various cerebral vascular disorders, including cerebral vasospasm. In this review, we focus on the current understanding of the use of gene transfer to the cerebral arteries for prevention and/or treatment of cerebral vasospasm following subarachnoid hemorrhage (SAH). We also discuss the recent developments in vascular therapeutics, involving the autologous use of progenitor cells for repair of damaged vessels, as well as a cell-based gene delivery approach for the prevention and treatment of cerebral vasospasm.

Original languageEnglish (US)
Pages (from-to)759-768
Number of pages10
JournalNeurological Research
Volume28
Issue number7
DOIs
StatePublished - Oct 2006

Fingerprint

Intracranial Vasospasm
Blood Vessels
Cerebral Arteries
Subarachnoid Hemorrhage
Genes
Stem Cells
Therapeutics

Keywords

  • Adenovirus
  • Endothelial nitric oxide synthase
  • Progenitor cells
  • Subarachnoid hemorrhage

ASJC Scopus subject areas

  • Clinical Neurology
  • Neuroscience(all)

Cite this

Genetic modification of cerebral arterial wall : Implications for prevention and treatment of cerebral vasospasm. / Vijay, Anantha; Santhanam, R.; Katusic, Zvonimir S.

In: Neurological Research, Vol. 28, No. 7, 10.2006, p. 759-768.

Research output: Contribution to journalArticle

@article{3e86734ffa2346cdb9ee0473e16c03e4,
title = "Genetic modification of cerebral arterial wall: Implications for prevention and treatment of cerebral vasospasm",
abstract = "Genetic modification of cerebral vessels represents a promising and novel approach for prevention and/or treatment of various cerebral vascular disorders, including cerebral vasospasm. In this review, we focus on the current understanding of the use of gene transfer to the cerebral arteries for prevention and/or treatment of cerebral vasospasm following subarachnoid hemorrhage (SAH). We also discuss the recent developments in vascular therapeutics, involving the autologous use of progenitor cells for repair of damaged vessels, as well as a cell-based gene delivery approach for the prevention and treatment of cerebral vasospasm.",
keywords = "Adenovirus, Endothelial nitric oxide synthase, Progenitor cells, Subarachnoid hemorrhage",
author = "Anantha Vijay and R. Santhanam and Katusic, {Zvonimir S}",
year = "2006",
month = "10",
doi = "10.1179/016164106X152034",
language = "English (US)",
volume = "28",
pages = "759--768",
journal = "Neurological Research",
issn = "0161-6412",
publisher = "Maney Publishing",
number = "7",

}

TY - JOUR

T1 - Genetic modification of cerebral arterial wall

T2 - Implications for prevention and treatment of cerebral vasospasm

AU - Vijay, Anantha

AU - Santhanam, R.

AU - Katusic, Zvonimir S

PY - 2006/10

Y1 - 2006/10

N2 - Genetic modification of cerebral vessels represents a promising and novel approach for prevention and/or treatment of various cerebral vascular disorders, including cerebral vasospasm. In this review, we focus on the current understanding of the use of gene transfer to the cerebral arteries for prevention and/or treatment of cerebral vasospasm following subarachnoid hemorrhage (SAH). We also discuss the recent developments in vascular therapeutics, involving the autologous use of progenitor cells for repair of damaged vessels, as well as a cell-based gene delivery approach for the prevention and treatment of cerebral vasospasm.

AB - Genetic modification of cerebral vessels represents a promising and novel approach for prevention and/or treatment of various cerebral vascular disorders, including cerebral vasospasm. In this review, we focus on the current understanding of the use of gene transfer to the cerebral arteries for prevention and/or treatment of cerebral vasospasm following subarachnoid hemorrhage (SAH). We also discuss the recent developments in vascular therapeutics, involving the autologous use of progenitor cells for repair of damaged vessels, as well as a cell-based gene delivery approach for the prevention and treatment of cerebral vasospasm.

KW - Adenovirus

KW - Endothelial nitric oxide synthase

KW - Progenitor cells

KW - Subarachnoid hemorrhage

UR - http://www.scopus.com/inward/record.url?scp=33750458365&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33750458365&partnerID=8YFLogxK

U2 - 10.1179/016164106X152034

DO - 10.1179/016164106X152034

M3 - Article

VL - 28

SP - 759

EP - 768

JO - Neurological Research

JF - Neurological Research

SN - 0161-6412

IS - 7

ER -